Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nantong
Clinical trial register · China

Clinical Trials in Nantong, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 5586 Shanghai 3885 Guangzhou 3356 Hangzhou 1825 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Affiliated Hospital of Nantong University35 Jiawei Jiang6 Fudan University5 Novartis Pharmaceuticals4 First Affiliated Hospital of Zhejiang University3
Site location
Beijing5586 Shanghai3885 Guangzhou3356 Hangzhou1825 Wuhan1342
All 625 locations
Target enrolment
to

Trials with a site in Nantong

99 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Hua Huang, MD, PhD
Phase 3
170
Beijing, Chongqing, Zhangzhou, Guangzhou, Wuhan, Nanjing, Nantong, Nanchang
2026-12-01
Not yet open
Integrating Wearable Monitoring and Clinical Data for Stroke Early Warning
NCT07908303Stroke, Ischemic Stroke, Recurrent Stroke, Transient Ischemic Attack
Affiliated Hospital of Nantong University
Observational
5,000
Nantong
2026-12-01
Not yet open
Affiliated Hospital of Nantong University
Observational
80
Nantong
2026-11-10
Not yet open
Affiliated Hospital of Nantong University
Observational
80
Nantong
2026-11-10
Not yet open
Remimazolam vs Propofol for Long-Term Sedation in Mechanically Ventilated ICU Patients
NCT07880548Long-term Sedation for Mechanical Ventilation, Critically Ill Intensive Care Unit Patients
Sun Yat-sen University
Phase 3
274
Dongguan, Guangzhou, Shenzhen, Nanning, Luoyang, Zhengzhou, Wuhan, Nantong
2026-10-20
Not yet open
Shanghai Jiao Tong University School of Medicine
Not applicable
120
Fuzhou, Nantong, Shanghai, Zhangjiagang
2026-10-08
Recruiting
TransThera Sciences (Nanjing), Inc.
Phase 2
182
Fuzhou, Guangzhou, Wuhan, Nanjing, Nantong, Jinan, Chengdu, Hangzhou
2026-09-18
Recruiting
Affiliated Hospital of Nantong University
Not applicable
300
Nantong
2026-09-12
Recruiting
Affiliated Hospital of Nantong University
Not applicable
1,696
Nantong
2026-09-01
Active, closed
Affiliated Hospital of Nantong University
Not applicable
100
Bengbu, Nantong, Hangzhou
2026-07-14
Not yet open
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
NCT07667517Albuminuria, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Diseases
DrugFinerenone
First Affiliated Hospital of Zhejiang University
Phase 4
148
Chongqing, Fuzhou, Foshan, Guangzhou, Nantong, Suqian, Suzhou, Xi'an
2026-07-01
Not yet open
Jiangsu Cancer Institute & Hospital
Phase 2
80
Changzhou, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Wuxi, Xuzhou
2026-06-15
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Hefei, Guangzhou, Wuhan, Nanjing, Nantong, Nanchang, Changchun, Jinan
2026-05-27
Recruiting
Yanbing Yu
Not applicable
142
Beijing, Nanning, Shijiazhuang, Nanjing, Nantong, Nanchang, Shanghai, Tianjin
2026-05-23
Recruiting
tDCS for Reducing the Incidence of OEI After Cesarean Section
NCT07569783Itching Symptoms, Itching Caused by Epidural Use of Opioids
Affiliated Hospital of Nantong University
Not applicable
104
Nantong
2026-05-10
Recruiting
AstraZeneca
Observational
2,100
Beijing, Changsha, Chengdu, Guangzhou, Haerbin, Jinan, Nantong, Shanghai
2026-03-06
Recruiting
Affiliated Hospital of Nantong University
Phase 2
30
Nantong
2026-02-25
Not yet open
Shanghai Jiao Tong University School of Medicine
Not applicable
363
Nantong, Wuxi
2026-02-15
Recruiting
Affiliated Hospital of Nantong University
Phase 4
136
Nantong
2026-01-15
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
30
Guangzhou, Zhengzhou, Wuhan, Xiangyang, Changsha, Nanjing, Nantong, Nanchang
2026-01-05
Recruiting
Jiawei Jiang
Not applicable
70
Nantong
2026-01-01
Recruiting
Effects of taVNS Combined With Dexmedetomidine on POVN
NCT07271147Postoperative Nausea and Vomiting
DrugDexmedetomidine
Affiliated Hospital of Nantong University
Not applicable
176
Nantong
2025-12-07
Recruiting
Affiliated Hospital of Nantong University
Observational
200
Nantong
2025-11-19
Recruiting
Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)
NCT07805967Multiple System Atrophy, Dementia With Lewy Bodies (DLB), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
Second Affiliated Hospital of Soochow University
Observational
500
Changshu, Huai'an, Kunshan, Nanjing, Nantong, Suqian, Suzhou, Xuzhou
2025-11-12
Active, closed
Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological Surgery
NCT07455253Venous Thromboembolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Gynecological Surgery
Affiliated Hospital of Nantong University
Observational
234
Nantong
2025-11-10
Recruiting
Grit Biotechnology
Early Phase 1
30
Nantong
2025-10-28
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Beijing, Fuzhou, Xiamen, Guangzhou, Zhengzhou, Changsha, Nanjing, Nantong
2025-09-30
Recruiting
Haiyan Pan
Not applicable
60
Nantong
2025-09-15
Recruiting
Screening of Predictive Biomarkers for Cardiorenal Syndrome
NCT07139626Cardiorenal Syndrome (CRS)
Haiyan Pan
Observational
150
Nantong
2025-09-15
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Nanjing, Nanning, Nantong
2025-09-02
Not yet open
Affiliated Hospital of Nantong University
Observational
121
Nantong
2025-09-01
Recruiting
Nuvation Bio Inc.
Phase 3
180
Beijing, Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Nantong, Nanchang
2025-08-21
Recruiting
Affiliated Hospital of Nantong University
Phase 2
30
Nantong
2025-08-01
Recruiting
Study of Sivelestat Sodium in OPCABG
NCT07118930Coronary Heart Disease, Coronary Artery Disease, Coronary Arterial Disease (CAD)
Affiliated Hospital of Nantong University
Phase 2
62
Nantong
2025-08-01
Recruiting
Beijing Tiantan Hospital
Phase 3
596
Beijing, Jiuquan, Shijiazhuang, Jiyuan, Lingbao, Nantong, Hangzhou
2025-07-30
Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
NCT06933472Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, ESRD (End-Stage Renal Disease), Dialysis
Alebund Pharmaceuticals
Phase 3
264
Beijing, Xiamen, Zhengzhou, Wuhan, Changsha, Nanjing, Nantong, Wuxi
2025-06-13
Recruiting
Novartis Pharmaceuticals
Observational
80
Hefei, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nantong, Nanchang, Changchun
2025-06-10
Not yet open
Affiliated Hospital of Nantong University
Phase 1/2
12
Nantong
2025-06-01
By invitation
The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.
NCT07077811Cardiovascular Diseases, Heart Failure, Atrial Fibrillation (AF), HFpEF - Heart Failure With Preserved Ejection Fraction
Affiliated Hospital of Nantong University
Not applicable
158
Nantong
2025-06-01
Active, closed
Amgen
Phase 4
102
Beijing, Guangzhou, Shenzhen, Luoyang, Wuhan, Changzhou, Huaian, Nantong
2025-05-24
Recruiting
Affiliated Hospital of Nantong University
Observational
210
Nantong
2025-04-21
Recruiting
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
NCT06935513Hypertension, Diabetes, Atrial Fibrillation, Dyslipidemia
Affiliated Hospital of Nantong University
Not applicable
300
Nantong
2025-04-20
Recruiting
First Affiliated Hospital of Zhejiang University
Phase 3
194
Hangzhou, Harbin, Hefei, Jinhua, Nanchang, Nantong, Shanghai, Ürümqi
2025-03-24
Recruiting
baotai Liang
Phase 2
96
Nanjing, Nantong
2025-03-19
Not yet open
Clinical Study on the Efficacy and Safety of Hydromorphone for ICU Analgesia
NCT06848452Analgesia, ICU Patients Requiring Invasive Mechanical Ventilation
Affiliated Hospital of Nantong University
Observational
300
Nantong
2025-03
Active, closed
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
33
Bengbu, Jiangmen, Xingtai, Harbin, Luohe, Changsha, Nanjing, Nantong
2025-02-20
Recruiting
Affiliated Hospital of Nantong University
Not applicable
600
Nantong
2025-01-01
Active, closed
The Role of Early Nursing Intervention in the High-risk Population of Gestational Diabetes
NCT06997835Early Nursing Intervention, Gestational Diabetes Mellitus
Yan Lu
Not applicable
200
Nantong
2025-01-01
Recruiting
Ying Wang
Not applicable
216
Nantong
2025-01-01
Recruiting
Affiliated Hospital of Nantong University
Phase 4
64
Nantong
2024-12-03
Recruiting
Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)
NCT03547232Acute Pancreatitis, Complication, Mortality Rate, Organ Failure, Multiple
DrugIndomethacin
Peking Union Medical College Hospital
Phase 4
1,504
Beijing, Guiyang, Baoding, Harbin, Dengzhou, Nanyang, Huaian, Nantong
2024-12-01
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Chengdu, Guangzhou, Nanchang, Nanjing, Nantong, Shandong, Shanghai, Tianjin
2024-11-27
Recruiting
Affiliated Hospital of Nantong University
Observational
40
Nantong
2024-11-09
Recruiting
Daishan Jiang
Not applicable
150
Nantong
2024-11-01
Recruiting
Clinical Study of SMILE 4.0-VISULYZE in Correcting Refractive Errors
NCT06982807Refractive Surgery, Myopia; Refractive Error
Affiliated Hospital of Nantong University
Not applicable
600
Nantong
2024-11-01
Recruiting
Affiliated Hospital of Nantong University
Not applicable
83
Nantong
2024-10-31
Recruiting
First Affiliated Hospital of Zhejiang University
Phase 2
35
Nanchang, Hangzhou, Harbin, Hefei, Jinhua, Nantong, Shanghai, Shanxi
2024-10-09
Active, closed
TS Triage of HR-HPV Positive Population and Its Accuracy Study
NCT07777094Cervical Precancerous Lesions, Cervical Cancer
Affiliated Hospital of Nantong University
Observational
300
Nantong
2024-10-01
By invitation
Bin Zhang
Observational
80
Nantong
2024-10-01
Recruiting
Affiliated Hospital of Nantong University
Not applicable
30
Nantong
2024-08-01
Recruiting
Affiliated Hospital of Nantong University
Phase 4
30
Nantong
2024-08-01
Recruiting
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2/3
216
Beijing, Changchun, Guangzhou, Hangzhou, Jinan, Nanning, Nantong, Qingdao
2024-07-30
Recruiting
A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries
NCT06539689Peripheral Arterial Disease, Stenosis, Dissection
FrontAce Scientific Co., Ltd
Not applicable
240
Beijing, Chongqing, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Nantong, Shanghai
2024-06-04
Recruiting
China National Center for Cardiovascular Diseases
Phase 4
240
Beijing, Nantong
2024-06-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
112
Changzhou, Nanjing, Nantong, Taizhou, Yancheng
2024-05-01
Recruiting
Fudan University
Phase 2
210
Fuzhou, Nantong, Shanghai, Hangzhou, Ningbo
2024-03-04
Recruiting
Suzhou Municipal Hospital
Not applicable
30
Nanjing, Nantong, Suzhou
2024-03-01
Recruiting
Affiliated Hospital of Nantong University
Not applicable
900
Nantong
2024-02-18
Recruiting
Jiawei Jiang
Not applicable
104
Nantong
2024-02-01
Recruiting
Jiawei Jiang
Not applicable
60
Nantong
2024-01-01
By invitation
Affiliated Hospital of Nantong University
Observational
300
Nantong
2023-12-10
Recruiting
Jiawei Jiang
Not applicable
100
Nantong
2023-12-01
Recruiting
Southeast University, China
Not applicable
404
Hefei, Jinjiang, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Taizhou
2023-11-27
By invitation
Children's Hospital of Fudan University
Observational
1,000
Yiyang, Nantong, Shanghai, Baoji, Quzhou
2023-11-16
Recruiting
Affiliated Hospital of Nantong University
Phase 1/2
30
Nantong
2023-11-13
Not yet open
Fudan University
Phase 4
384
Shijiazhuang, Zhengzhou, Changsha, Nantong, Yangzhou, Shanghai, Hangzhou, Jiaxin
2023-10
Recruiting
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy
NCT06756321Relapsed/refractory Lymphoma, Relapsed/Refractory Leukemia
DrugsFludarabine·Cyclophosphamide
Affiliated Hospital of Nantong University
Early Phase 1
9
Nantong
2023-09-18
Active, closed
Jiawei Jiang
Observational
500
Nantong
2023-09-01
Recruiting
Fudan University
Phase 3
764
Beijing, Chongqing, Fuzhou, Guangzhou, Guangdong, Nantong, Yangzhou, Shenyang
2023-06-20
Recruiting
Fudan University
Phase 3
766
Beijing, Chongqing, Fuzhou, Guangzhou, Guangdong, Nantong, Yangzhou, Shenyang
2023-06-01
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
103
Nanjing, Nantong
2023-04-01
Active, closed
Bristol-Myers Squibb
Phase 3
606
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nantong
2023-01-10
Recruiting
Affiliated Hospital of Nantong University
Not applicable
88
Nantong
2022-10-01
Recruiting
Latent Infection Freshmen Tracking for Tuberculosis
NCT07811518Latent Tuberculosis Infection (LTBI), Tuberculosis (TB)
Affiliated Hospital of Nantong University
Phase 4
3,000
Nantong, Meishan
2022-08-15
Recruiting
Fudan University
Observational
385
Hefei, Shijiazhuang, Zhengzhou, Nantong, Taishing, Taizhou, Xi'an, Tianjin
2022-07-18
Recruiting
Urine and Ultrasound Screening for Kidney Disease in Children
NCT06018831Kidney Diseases, Diagnostic Techniques, Ultrasound, Urinalysis
Children's Hospital of Fudan University
Not applicable
13,000
Nantong, Suzhou
2022-04-12
By invitation
Intravitreal and Intracameral DEX in NPDR
NCT06951087Non-Proliferative Diabetic Retinopathy
DrugDexamethasone Sodium Phosphate
Affiliated Hospital of Nantong University
Phase 3
80
Nantong
2022-01-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Guangzhou, Changsha, Nanjing, Nantong, Shanghai
2021-04-21
Active, closed
Karyopharm Therapeutics Inc
Phase 2
112
Beijing, Wuhan, Nantong, Suzhou, Changchun, Hangzhou
2021-03-17
Active, closed
Novartis Pharmaceuticals
Phase 3
345
Lanzhou, Foshan, Guangzhou, Shijiazhuang, Baotou, Hohhot, Nanjing, Nantong
2021-03-01
Active, closed
Celgene
Phase 3
313
Guangzhou, Nanyang, Changsha, Nanjing, Nantong, Nanchang, Qingdao, Taiyuan
2021-02-25
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Dongguan, Fuzhou, Baotou, Nanjing, Nantong, Shanghai, Chengdu, Ürümqi
2020-12-11
Active, closed
Hoffmann-La Roche
Phase 3
210
Beijing, Guangzhou, Hangzhou, Nanjing, Nantong, Shanghai, Wuhan
2020-10-08
Recruiting
Jiawei Jiang
Not applicable
100
Nantong
2020-03-01
Recruiting
Affiliated 2 Hospital of Nantong University
Observational
300
Nantong
2020-01-01
Active, closed
Pfizer
Phase 3
1,068
Hefei, Beijing, Fuzhou, Wuhan, Changsha, Nanjing, Nantong, Suzhou
2019-12-30
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
690
Hefei, Nanyang, Nantong, Xuzhou, Yancheng, Jinan, Shanghai, Hangzhou
2019-10-01
Active, closed
Pfizer
Phase 3
1,054
Hefei, Beijing, Fuzhou, Xiamen, Wuhan, Lianyungang, Nanjing, Nantong
2017-12-18
Recruiting
Affiliated 2 Hospital of Nantong University
Observational
300
Nantong
2016-01
Rows per page Showing 1–99 of 99
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/nantong

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 99 of those studies with a site in Nantong.

How many clinical trials are recruiting in Nantong?

65 of the 99 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 13 have not yet opened recruitment, 16 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nantong), 99 studies
PhaseStudiesRecruitingShare
Not applicable302530.3%
Observational221122.2%
Phase 319919.2%
Phase 213913.1%
Phase 4969.1%
Early Phase 1222%
Phase 1/2212%
Phase 2/3222%

Most active sponsors

Lead sponsors with the most studies (Nantong)
Lead sponsorStudiesRecruiting
Affiliated Hospital of Nantong University3523
Jiawei Jiang65
Fudan University54
Novartis Pharmaceuticals42
First Affiliated Hospital of Zhejiang University32
Affiliated 2 Hospital of Nantong University22
AstraZeneca22
Bristol-Myers Squibb21
Children's Hospital of Fudan University21
Haiyan Pan22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.